Leal-Ramos, O.J.; Arias-Ruiz, L.F.; Huerta-Velázquez, J.M.; Lamoreaux-Aguayo, J.P.; Butcher, D.; López-Cuellar, A.B.; Orozco-Jiménez, K.I.; Torres-BugarÃn, O.
Mechanisms Involved in the Adverse Cardiovascular Effects of Selective Cyclooxygenase-2 Inhibitors. Cardiovasc. Med. 2025, 28, 5.
https://doi.org/10.3390/cardiovascmed28010005
AMA Style
Leal-Ramos OJ, Arias-Ruiz LF, Huerta-Velázquez JM, Lamoreaux-Aguayo JP, Butcher D, López-Cuellar AB, Orozco-Jiménez KI, Torres-BugarÃn O.
Mechanisms Involved in the Adverse Cardiovascular Effects of Selective Cyclooxygenase-2 Inhibitors. Cardiovascular Medicine. 2025; 28(1):5.
https://doi.org/10.3390/cardiovascmed28010005
Chicago/Turabian Style
Leal-Ramos, Oscar Jesus, Luis Felipe Arias-Ruiz, José Miguel Huerta-Velázquez, José Pablo Lamoreaux-Aguayo, Dalton Butcher, Asela Berenice López-Cuellar, Karina Iveth Orozco-Jiménez, and Olivia Torres-BugarÃn.
2025. "Mechanisms Involved in the Adverse Cardiovascular Effects of Selective Cyclooxygenase-2 Inhibitors" Cardiovascular Medicine 28, no. 1: 5.
https://doi.org/10.3390/cardiovascmed28010005
APA Style
Leal-Ramos, O. J., Arias-Ruiz, L. F., Huerta-Velázquez, J. M., Lamoreaux-Aguayo, J. P., Butcher, D., López-Cuellar, A. B., Orozco-Jiménez, K. I., & Torres-BugarÃn, O.
(2025). Mechanisms Involved in the Adverse Cardiovascular Effects of Selective Cyclooxygenase-2 Inhibitors. Cardiovascular Medicine, 28(1), 5.
https://doi.org/10.3390/cardiovascmed28010005